Found: 25
Select item for more details and to access through your institution.
Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1493, doi. 10.1111/dom.13668
- By:
- Publication type:
- Article
Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1299, doi. 10.1111/dom.13649
- By:
- Publication type:
- Article
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes ( REWIND) trial on the cardiovascular effects of dulaglutide.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 42, doi. 10.1111/dom.13028
- By:
- Publication type:
- Article
Teriparatide for Acceleration of Fracture Repair in Humans: A Prospective, Randomized, Double-Blind Study of 102 Postmenopausal Women With Distal Radial Fractures.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 2, p. 404, doi. 10.1359/jbmr.090731
- By:
- Publication type:
- Article
Pelvic Radioiodine Uptake in a Rectal Wall Teratoma After Thyroidectomy for Papillary Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 1992, v. 33, n. 10, p. 1848
- By:
- Publication type:
- Article
944-P: HbA1c Change Is Associated with Retinopathy Outcomes during GLP-1RA CVOT Follow-Up.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-944-P
- By:
- Publication type:
- Article
924-P: Exploring Potential Mediators of the Cardiovascular Benefit of Dulaglutide in REWIND.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-924-P
- By:
- Publication type:
- Article
233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-233-OR
- By:
- Publication type:
- Article
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01594-6
- By:
- Publication type:
- Article
Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01386-4
- By:
- Publication type:
- Article
Healthcare Use among U.S. Women Aged 45 and Older: Total Costs and Costs for Selected Postmenopausal Health Risks.
- Published in:
- Journal of Women's Health & Gender-Based Medicine, 1999, v. 8, n. 8, p. 1077, doi. 10.1089/jwh.1.1999.8.1077
- By:
- Publication type:
- Article
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 8, p. e3448, doi. 10.1210/clinem/dgac200
- By:
- Publication type:
- Article
Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1805, doi. 10.1002/ejhf.2670
- By:
- Publication type:
- Article
Hindsight Bias: An Impediment to Accurate Probability Estimation in Clinicopathologic Conferences.
- Published in:
- Medical Decision Making, 1988, v. 8, n. 4, p. 259, doi. 10.1177/0272989X8800800406
- By:
- Publication type:
- Article
Lithium as a Potential Adjuvant to <sup>131</sup>I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma*.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1999, v. 84, n. 3, p. 912, doi. 10.1210/jcem.84.3.5527
- By:
- Publication type:
- Article
CHANGES IN BLOOD PRESSURE AND PLASMA NORADRENALINE IN SHORT-TERM HYPOTHYROIDISM.
- Published in:
- Clinical Endocrinology, 1989, v. 30, n. 6, p. 635, doi. 10.1111/j.1365-2265.1989.tb00268.x
- By:
- Publication type:
- Article
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01179-1
- By:
- Publication type:
- Article
Carnitine Is a Naturally Occurring Inhibitor of Thyroid Hormone Nuclear Uptake.
- Published in:
- Thyroid, 2000, v. 10, n. 12, p. 1043, doi. 10.1089/thy.2000.10.1043
- By:
- Publication type:
- Article
Mobilization of Mg<sup>2+</sup> from Rat Heart and Liver Mitochondria following the Interaction of Thyroid Hormone with the Adenine Nucleotide Translocase.
- Published in:
- Thyroid, 1996, v. 6, n. 5, p. 513, doi. 10.1089/thy.1996.6.513
- By:
- Publication type:
- Article
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
- Published in:
- European Heart Journal, 2021, v. 42, n. 26, p. 2565, doi. 10.1093/eurheartj/ehaa777
- By:
- Publication type:
- Article
Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis.
- Published in:
- Diabetes Care, 2023, v. 46, n. 5, p. 1046, doi. 10.2337/dc22-2397
- By:
- Publication type:
- Article
HbA<sub>1c</sub> Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1).
- Published in:
- Diabetes Care, 2014, v. 37, n. 8, p. 2159, doi. 10.2337/dc13-2760
- By:
- Publication type:
- Article
Effect of Raloxifene on Serum Triglycerides in Women With a History of Hypertriglyceridemia While on Oral Estrogen Therapy.
- Published in:
- Diabetes Care, 2005, v. 28, n. 7, p. 1555, doi. 10.2337/diacare.28.7.1555
- By:
- Publication type:
- Article